Abstract
Background: Cortical folding is essential for healthy brain development. Previous studies have found regional reductions in cortical folding in adult patients with psychotic illness. It is unknown whether these neuroanatomical markers are present in youth with subclin-ical psychotic symptoms. Methods: We collected MRIs and examined the local gyrification index in a sample of 110 youth (mean age ± standard deviation 14.0 ± 3.7 yr; range 9–25 yr) with a family history of severe mental illness: 48 with psychotic symptoms and 62 with-out. Images were processed using the Human Connectome Pipeline and FreeSurfer. We tested for group differences in local gyrifica-tion index using mixed-effects generalized linear models controlling for age, sex and familial clustering. Sensitivity analysis further controlled for intracranial volume, IQ, and stimulant and cannabis use. Results: Youth with psychotic symptoms displayed an overall trend toward lower cortical folding across all brain regions. After adjusting for multiple comparisons and confounders, regional reductions were localized to the frontal and occipital lobes. Specifically, the medial (B = –0.42, pFDR = 0.04) and lateral (B = –0.39, pFDR = 0.04) orbi-tofrontal cortices as well as the cuneus (B = –0.47, pFDR = 0.03) and the pericalcarine (B = –0.45, pFDR = 0.03) and lingual (B = –0.38, pFDR = 0.04) gyri. Limitations: Inference about developmental trajectories was limited by the cross-sectional data. Conclusion: Psychotic symptoms in youth are associated with cortical folding deficits, even in the absence of psychotic illness. The current study helps clarify the neurodevelopmental basis of psychosis at an early stage, before medication, drug use and other confounds have had a persistent effect on the brain.
Original language | English |
---|---|
Pages (from-to) | 125-133 |
Number of pages | 9 |
Journal | Journal of Psychiatry and Neuroscience |
Volume | 45 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2020 |
Bibliographical note
Funding Information:This project was supported by the Independent Investigator Award, Brain & Behavior Research Foundation (R. Uher; grant number 24684), the Canada Research Chairs Program (award number 231397), the Canadian Institutes of Health Research (grant reference numbers 124976, 142738 and 148394), the Nova Scotia Health Authority and the Dalhousie Medical Research Foundation. V. Drobinin was supported by the Canadian Institutes of Health Research doctoral award (157975). The Biomedical Translational Imaging Centre (BIOTIC) has received funding support from Brain Canada.
Funding Information:
Acknowledgements: This project was supported by the Independent Investigator Award, Brain & Behavior Research Foundation (R. Uher; grant number 24684), the Canada Research Chairs Program (award number 231397), the Canadian Institutes of Health Research (grant reference numbers 124976, 142738 and 148394), the Nova Scotia Health Authority and the Dalhousie Medical Research Foundation. V. Drobinin was supported by the Canadian Institutes of Health Research doctoral award (157975). The Biomedical Translational Imaging Centre (BIOTIC) has received funding support from Brain Canada.
Publisher Copyright:
© 2020 Joule Inc. or its licensors.
ASJC Scopus Subject Areas
- Psychiatry and Mental health
- Biological Psychiatry
- Pharmacology (medical)